Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 1/7/2020
SIETES contiene 93059 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Soh CH, Oleske JM, Brady MT, Spector SA, Borkowsky W, Burchett SK, Foca MD, Handelsman E, Jiménez E, Dankner WM, Hughes MD, for the Pediatric AIDS Clinical Trials Group. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003;362:2045-51. [Ref.ID 68527]
2.
Demeter LM, Hughes MD, Coombs RW, Jackson B, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med 2001;135:954-64. [Ref.ID 59905]
3.Tiene citas relacionadas Cita con resumen
Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage R, Manion D, Ruiz N M, Gersten M, Becker M, McNamara J, Mofenson LM, for the Pediatric AIDS Clinical Trials Group 382 Team. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. N Engl J Med 1999;341:1874-81. [Ref.ID 48102]
4. Cita con resumen
Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly W G, He W, Phillips L, Craven D, Van der Horst C, Feinberg J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332:693-9. [Ref.ID 23796]
5.
Collier AC, Bozzette S, Coombs RW, Causey DM, Schoenfeld DA, Spector SA, Pettinelli C B, Davies G, Richman D D, Leedom JM, Kidd P, Corey L. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med 1990;323:1015-21. [Ref.ID 15591]
Seleccionar todas
 
 1 a 5 de 5